Amedisys Reports Fourth Quarter and Year End 2017 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Amedisys Reports Fourth Quarter and Year End 2017 Financial Results

Amedisys (AMED) Misses Q4 EPS by 2c, Offers Guidance

February 27, 2018 5:03 PM EST

Amedisys (NASDAQ: AMED) reported Q4 EPS of $0.56, $0.02 worse than the analyst estimate of $0.58. Revenue for the quarter came in at $404.2 million versus the consensus estimate of $394.62 million.

GUIDANCE:

Amedisys sees FY2018 EPS of $2.97-$3.08, may not compare to the consensus... More